Cardiosonic Inc. announced the completion of the first phase of patient enrollment in its first-in-man (FIM) TIVUS I clinical study. The study is designed to collect data on the safety and performance of the TIVUS System, a high intensity, non-focused therapeutic ultrasound catheter system for remote tissue ablation for the treatment of hypertension by renal denervation (RDN).

April 23, 2013 — In March, Radial Assist LLC received CE mark approval to sell its product portfolio to the European community. The company developed the patented Rad Board, a scatter radiation protective arm board used to facilitate upper extremity diagnostic and interventional medical procedures. 

The results of a pivotal benchmark study of Silicon BioDevices’ digital handheld device for high-sensitivity measure­ment of cardiac troponin-I, a protein found in the heart muscle used to identify heart tissue dam­age in patients suspected of having a heart attack, showed that the totally integrated, single-use device was able to provide troponin test results in one step directly from a drop of blood in 15 minutes with performance comparable to clinical lab instrumentation.